Company: BIAF
Filing Date: 2025-05-02
Form Type: S-1
Source: 0001641172-25-008170
Chunk: 175

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-02
Form: S-1
Chunk 175
---
 accordance with the rules and regulations of the SEC, provided that any increase in the beneficial ownership limitation shall not be effective until 61 days following notice to us.

Cashless Exercise

If, at the time after the later of the six month anniversary of the date of issuance of the April 2025 Warrants and the date of Warrant Stockholder Approval, a holder exercises its April 2025 Warrants and a registration statement registering the issuance of the shares of Common Stock underlying the April 2025 Warrants under the Securities Act is not then effective or available for the issuance of such shares, then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock determined according to a formula set forth in the April 2025 Warrants.

| 82 |

Fractional Shares

No fractional shares of Common Stock will be issued upon the exercise of the April 2025 Warrants. Rather, the number of shares of Common Stock to be issued will be rounded up to the next whole share or we will pay a cash adjustment equal to such fraction multiplied by the exercise price to the holder.

Transferability

Subject to applicable laws, a warrant may be transferred at the option of the holder upon surrender of the warrant to us together with the appropriate instruments of transfer.

Trading Market

There is no trading market available for the April 2025 Warrants on any securities exchange or nationally recognized trading system, and we do not expect a trading market to develop. We do not intend to list the April 2025 Warrants on any securities exchange or other trading market. Without a trading market, the liquidity of the April 2025 Warrants will be extremely limited. The Common Stock issuable upon exercise of the April 2025 Warrants is currently listed on the Nasdaq Capital Market.

Rights as a Stockholder

Except as otherwise provided in the April 2025 Warrants or by virtue of such holder’s ownership of shares of our Common Stock, the holders of the April 2025 Warrants do not have the rights or privileges of holders of our Common Stock, including any voting rights, until they exercise their April 2025 Warrants.

Warrant Agent; Global Certificates.

The April 2025 Warrants will
be issued in registered form under a Warrant Agent Agreement between the Warrant Agent and us. The April 2025 W